Metabolomic profile of pulmonary neuroendocrine neoplasms

This research project aims to develop an innovative blood test for earlier detection of an important subtype of lung tumors, known as neuroendocrine neoplasms (NENs). Unfortunately, these tumors are too often diagnosed late and are difficult to treat. Our approach is to exploit a specific characteristic of neoplasms: tumor cells adapt the way they generate and use energy. By analyzing chemical substances called metabolites in the blood, we hope to create a test that would enable these tumors to be diagnosed more quickly and accurately. Biomark Diagnostics Inc. provides measurement of the concentrations of these metabolites in patients’ blood using an innovative physical technology called Luxon ion source®. By identifying biomarkers, patients could then be diagnosed earlier and receive treatment, which could improve their quality of life, prognosis and chances of recovery. This project offers the opportunity to contribute to important medical advances in the detection and treatment of NENs, which could lead to better therapeutic options for patients.

Faculty Supervisor:

Philippe Joubert;Venkata Manem

Student:

Partner:

Biomark Diagnostic Solutions Inc

Discipline:

Life Sciences

Sector:

Health and Related Sciences and Technology; Technology; Artificial Intelligence

University:

Université Laval

Program: